DE69819515D1 - Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion - Google Patents

Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion

Info

Publication number
DE69819515D1
DE69819515D1 DE69819515T DE69819515T DE69819515D1 DE 69819515 D1 DE69819515 D1 DE 69819515D1 DE 69819515 T DE69819515 T DE 69819515T DE 69819515 T DE69819515 T DE 69819515T DE 69819515 D1 DE69819515 D1 DE 69819515D1
Authority
DE
Germany
Prior art keywords
prostagland
hydroxy
derivatives
erectile dysfunction
treating erectile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69819515T
Other languages
English (en)
Other versions
DE69819515T2 (de
Inventor
Johan Stjernschantz
Bahram Resul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphora AB
Original Assignee
Synphora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora AB filed Critical Synphora AB
Publication of DE69819515D1 publication Critical patent/DE69819515D1/de
Application granted granted Critical
Publication of DE69819515T2 publication Critical patent/DE69819515T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
DE69819515T 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion Expired - Fee Related DE69819515T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence
SE9702681 1997-07-10
PCT/SE1998/001367 WO1999002164A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69819515D1 true DE69819515D1 (de) 2003-12-11
DE69819515T2 DE69819515T2 (de) 2004-09-23

Family

ID=20407719

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819515T Expired - Fee Related DE69819515T2 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion

Country Status (8)

Country Link
US (1) US6476074B1 (de)
EP (1) EP1003520B1 (de)
JP (1) JP2001509485A (de)
AU (1) AU752049B2 (de)
CA (1) CA2295721A1 (de)
DE (1) DE69819515T2 (de)
SE (1) SE9702681D0 (de)
WO (1) WO1999002164A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
WO2000051978A1 (en) 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
WO2001024800A1 (fr) * 1999-10-07 2001-04-12 Ono Pharmaceutical Co., Ltd. Remedes contre le dysfonctionnement de l'erection
IL139941A0 (en) * 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
PT1132086E (pt) 2000-01-31 2006-09-29 Pfizer Prod Inc Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
AU2001278680A1 (en) * 2000-07-31 2002-02-13 Ono Pharmaceutical Co. Ltd. Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
AU2002328338C1 (en) 2001-07-16 2009-01-08 Ono Pharmaceutical Co., Ltd 2 pyrrolidone derivatives as prostanoid agonists
KR20070087078A (ko) 2001-07-23 2007-08-27 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하 질환의치료제
EP1513589B1 (de) * 2002-06-06 2010-11-10 Merck Frosst Canada Ltd. 1,5-disubstituierte pyrrolid-2-on-derivate zur verwendung als ep4 rezeptor agonisten zur behandlung von augenkrankheiten wie z.b. glaukom
EP1563846B1 (de) 2002-10-10 2012-08-29 Ono Pharmaceutical Co., Ltd. Endogene reparaturfaktoren herstellende promoter
AU2004216857A1 (en) 2003-03-03 2004-09-16 Laboratoires Serono Sa G-lactam derivatives as prostaglandin agonists
AU2004261397A1 (en) 2003-07-18 2005-02-10 Laboratoires Serono Sa Hydrazide derivatives as prostaglandin receptors modulators
EP1824819B1 (de) 2004-12-06 2010-01-20 Merck Serono SA Pyrrolidin-2-on-Derivate zur Verwendung als DP1-Rezeptoragonisten
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
AU2007233212B2 (en) * 2006-04-04 2012-09-13 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
EP2913047B1 (de) 2012-10-29 2019-05-08 Cardio Incorporated Spezifisches therapeutikum für pulmonale erkrankungen
WO2015056504A1 (ja) 2013-10-15 2015-04-23 小野薬品工業株式会社 薬剤溶出性ステントグラフト
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
CA2295721A1 (en) 1999-01-21
US6476074B1 (en) 2002-11-05
EP1003520B1 (de) 2003-11-05
SE9702681D0 (sv) 1997-07-10
DE69819515T2 (de) 2004-09-23
AU8368298A (en) 1999-02-08
JP2001509485A (ja) 2001-07-24
WO1999002164A1 (en) 1999-01-21
EP1003520A1 (de) 2000-05-31
AU752049B2 (en) 2002-09-05

Similar Documents

Publication Publication Date Title
DE69819515D1 (de) Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
FI972205A (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69812603T2 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
IL141553A0 (en) Drug preparations for treating sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
EP1027054A4 (de) Lokale anwendung von phosphodiesterase inhibitoren zur behandlung der erektilen dysfunktion
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
HUP0103346A3 (en) Composition and method for treating penile erectile dysfunction
NO20000085D0 (no) Forbedrede metoder og sammensetninger for behandling av erektil dysfunksjon hos menn
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DE69841352D1 (de) Vorrichtung zur Abwasserbehandlung
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE814775T1 (de) Methode und kit zur verhütung erektiler dysfunktion
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
NO995823L (no) Terapeutisk middel for ereksjonsdysfunksjon
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
ID27191A (id) Metode untuk pengobatan insomnia
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
ATE236884T1 (de) Pde-iv hemmende 2-cyanoiminoimidazol-derivate
NO990805L (no) Middel for ereksjonssvikt omfattende kondenserte pyridazinforbindelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee